Aimmune Therapeutics

AIMT

19.77

+0.10

+0.5%

Stock Price
Open: 19.67
Prev. Close: 19.67
Low/Hi: 19.59 - 19.82
52-Week: 9.77 - 27.31
Volumes
Equity: 1,989
90-Day Avg: 324,743
Option:
90-Day Avg: 29
Volatility
Today: 9.5
20-Day: 36.2
52-Week: 54.1
30-Day IV: 40.8 -2.9
IV Rank: 0.22 (Subdued)
Fundamental
Div. Yield: 0.0%
Earnings: 22-Jun (Est.)
P/E Ratio:
Market Cap: 989.7 M
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

AIMT Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 30-Sep-2016 30-Jun-2016 31-Mar-2016
Cash and Cash Equivalents 124,010 76,911 74,430 65,045
Short Term Investments 124,921 73,332 94,538 115,234
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 2,749 2,338 3,782 4,952
Net Property Plant and Equipment 10,391 9,034 7,032 3,699
Other Current Assets 0 0 0 0
Current Assets 251,680 152,581 172,750 185,231
Goodwill and Intangibles 0 0 0 0
Long Term Investments 33,602 9,012 2,804 6,697
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 298,789 173,727 185,696 199,929
Short Term Debt 0 0 0 0
Other Non-Current Assets 3,116 3,100 3,110 4,302
Accounts Payable 1,427 1,470 1,261 1,791
Accrued Liabilities and Other Payables 9,921 10,249 4,433 3,395
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 12,817 13,228 7,167 6,531
Other Current Liabilities 102 128 150 133
Accumulated Other Comprehensive Income -27 14 31 6
Preferred Stock 0 0 0 0
Current Liabilities 11,450 11,847 5,844 5,319
Common Stock 5 4 4 4
Other Non-Current Liabilities 1,367 1,381 1,323 1,212
Additional Paid-In Capital 420,151 269,562 265,489 262,244
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -134,157 -109,081 -86,995 -68,856
Total Equity 285,972 160,499 178,529 193,398
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Cash and Cash Equivalents 124,010 76,677 2,269
Short Term Investments 124,921 115,158 0
Investments - - -
Accounts Receivable 0 0 0
Inventory 0 0 0
Loans - - -
Prepaid Expenses 2,749 5,622 106
Net Property Plant and Equipment 10,391 2,702 87
Other Current Assets 0 0 0
Current Assets 251,680 197,457 2,375
Goodwill and Intangibles 0 0 0
Long Term Investments 33,602 7,992 0
Other Assets - - -
Long Term Receivables 0 0 0
Total Assets 298,789 212,361 2,531
Short Term Debt 0 0 0
Other Non-Current Assets 3,116 4,210 69
Accounts Payable 1,427 1,863 478
Accrued Liabilities and Other Payables 9,921 3,118 1,259
Long Term Debt 0 0 0
Other Liabilities - - -
Current Portion of Long Term Debt 0 0 0
Total Liabilities 12,817 6,110 1,860
Other Current Liabilities 102 117 67
Accumulated Other Comprehensive Income -27 -88 0
Preferred Stock 0 0 16,928
Current Liabilities 11,450 5,098 1,804
Common Stock 5 4 0
Other Non-Current Liabilities 1,367 1,012 56
Additional Paid-In Capital 420,151 259,668 1,260
Treasury Stock 0 0 0
Other Equity 0 0 0
Retained Earnings -134,157 -53,333 -17,517
Total Equity 285,972 206,251 671